India Glycols Limited’s Board of Directors approved the Unaudited Financial Results for the quarter and nine months ended December 31, 2025, on February 10, 2026. The meeting lasted from 16:00 Hrs. to 17:12 Hrs. Key standalone highlights include Profit Before Tax of ₹88.30 Crore for the quarter, against ₹72.49 Crore in the previous corresponding quarter. Consolidated Profit Before Tax reached ₹90.61 Crore for the quarter.
Financial Results Approval Announcement
India Glycols Limited officially communicated the outcome of its Board Meeting held on February 10, 2026. During this meeting, the Board, having reviewed the reports from the Audit Committee, approved the Unaudited Financial Results for both Standalone and Consolidated operations for the quarter and nine months that concluded on December 31, 2025.
Standalone Financial Performance Highlights (Q3 FY2026)
The performance across the standalone entity showed notable growth:
- Revenue from operations stood at ₹2,551.06 Crore for the quarter ended December 31, 2025.
- Profit Before Tax for the quarter was ₹88.30 Crore, compared to ₹72.49 Crore in the quarter ending December 31, 2024.
- Profit After Tax for the quarter was ₹65.26 Crore.
- For the nine months ended December 31, 2025, the Profit After Tax was ₹172.05 Crore.
- Basic Earnings Per Share (EPS) for the quarter was ₹10.42 (restated).
Consolidated Financial Performance Summary
The consolidated results, which include the Group’s performance:
- Consolidated Total Income for the quarter reached ₹2,551.84 Crore.
- Profit Before Tax for the quarter was ₹90.61 Crore, an increase from ₹83.61 Crore year-over-year.
- The consolidated Profit After Tax attributable to owners of the Company for the quarter stood at ₹67.57 Crore.
- For the nine months period ending December 31, 2025, the consolidated Profit After Tax was ₹205.88 Crore.
- Consolidated Basic EPS for the quarter was ₹10.79 (restated).
Segment Performance Snapshot (Standalone)
Segment results show the key contributions to Profit Before Interest and Tax (PBT) for the quarter:
- Bio-based Specialities and Performance Chemicals: PBT of ₹41.13 Crore.
- Potable Spirits: PBT of ₹72.43 Crore.
- Bio-Fuel: PBT of ₹32.99 Crore.
Corporate Actions and Notes
The directors noted several significant corporate events:
- The Board reaffirmed its focus on the Demerger, setting the appointed date for the Scheme of Arrangement as April 1, 2026, while discontinuing the earlier amalgamation proposal involving Kashipur Holdings Limited (KHL).
- The financial statements reflect the impact of the Stock Split/Sub-division completed in August 2025, which resulted in EPS figures being restated for all previous periods.
- An Exceptional Item expense of ₹0.83 Crore related to the implementation of the New Labour Codes was recognized during the period.
- Fundraising activities concluded in November 2025, leading to an increase in paid-up share capital to ₹33,51,33,825 effective January 6, 2026.
The financial statements carry the review report from K.N. Gutgutia & Co., Chartered Accountants, confirming that the disclosures comply with applicable accounting standards.
Source: BSE
